Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Dioslife-1000 - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Dioslife-1000

Approved

STANDARD

Dioslife-1000

Flourish Pharma🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: c213c1fa9eb9b503
Company: Flourish Pharma
Type: Standard

Approval Details

Approval Id: c213c1fa9eb9b503
Drug Approval Philippines Name: Dioslife-1000
Product Name: Dioslife-1000
Registration Number: DRP-15339
Brand Name: Dioslife-1000
Generic Name: Diosmin + Hesperidin
Dosage Form: Film-coated Tablet
Dosage Strength: 900 mg/100 mg
Manufacturer: Flourish Pharma
Importer: Biophil Medical Equipment and Supplies Trading
Distributor: Biophil Medical Equipment and Supplies Trading
Issuance Date: 25 June 2024
Expiry Date: 25 June 2029
Pharmacologic Category: Vasoprotective (Capillary Stabilizing Agent)
Classification: Over-the-Counter (OTC) Drug

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

c213c1fa9eb9b503

Type

Standard

Back to Philippines FDA Approvals